Search

Search results

Genetic testing: an essential topic for discussion with the IRD community

As Luxturna reaches the clinic and other gene-specific therapies for inherited retinal disease get closer to the end of the development pipeline, it is becoming ever more important that affected families can access a genetic diagnosis, potentially opening up choices around treatment and clinical trial participation.

Hajrah Sarkar in the Lab

Researcher profiles

Research into inherited retinal conditions is one of the key objectives of Retina UK.